ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for people who are considering taking part in clinical trials and would like to find out more about what’s involved, why clinical trials are important and what the benefits of taking part in trials are. You can also find out about current clinical trials going on in ICTU and how to get involved.

Clinical Trials Search


CurrentAll Trials


Trial Details

  • Trial statusAnalysis
  • Study email contactipet-trial@imperial.ac.uk
  • Chief InvestigatorCarlo Palmieri
  • SponsorImperial College London
  • PhaseII

A phase II, open label, preoperative study to assess the efficacy of the novel steroid sulfatase inhibitor Irosustat in postmenopausal women with early oestrogen receptor positive breast cancer.

Design and Objective

Primary Objective: To assess changes in [18F] fluorothymidine (FLT) uptake using Positron Emission Tomography (PET) following 2 weeks of Irosustat treatment in patients with early, treatment naïve, oestrogen receptor positive (ER +ve) breast cancer.

Key inclusion criteria

18 years of age or older Postmenopausal Histologically confirmed ER +ve breast cancer (Allred >3). Tumour measuring ≥15mm in longest diameter ECOG performance status 0, 1 or 2 Adequate bone marrow, renal and liver function No evidence of bleeding diathesis Written informed consent to participate in the trial and to donate tissue and blood samples

Study Disclaimer Statement